Brad Evans
Senior Scientific Advisor BioIVT
Seminars
Wednesday 22nd July 2026
The Evolution of Oncology Biomarker Discovery: Why Multi-Omic Strategies are Reshaping Translational Research
12:00 pm
- Exploring the shift in oncology biomarker discovery from single-analyte, genomics-focused methods to integrated multi-omic strategies
- Highlighting the limitations of genomics-only approaches and demonstrating how combining analyte classes such as cfRNA, proteins, extracellular vesicles, and spatial tumor biology enhances understanding of treatment response and disease progression
- Unlocking practical guidance for designing robust multi-omic biomarker workflows and structuring translational studies for improved clinical relevance
